1 INTRODUCTION
1.1 Study Deliverables
1.2 Study Assumptions
1.3 Scope of the Study

2 RESEARCH METHODOLOGY

3 EXECUTIVE SUMMARY

4 MARKET DYNAMICS
4.1 Market Overview
4.2 Market Drivers
4.2.1 Increasing Global Prevalence of Stress and Life-style Disorders among Men and Women
4.2.2 Rise in Healthcare Awareness along with Increasing Aging Female Population
4.3 Market Restraints
4.3.1 Stringent Regulatory Framework that Delays the Approval of Products
4.3.2 Expensive Patented Products
4.4 Porter's Five Force Analysis
4.4.1 Threat of New Entrants
4.4.2 Bargaining Power of Buyers/Consumers
4.4.3 Bargaining Power of Suppliers
4.4.4 Threat of Substitute Products
4.4.5 Intensity of Competitive Rivalry

5 MARKET SEGMENTATION
5.1 By Drug Class
5.1.1 Gonadotrophins
5.1.2 Aromatase Inhibitors
5.1.3 Selective Estrogen Receptor Modulators (SERMs)
5.1.4 Biguanides
5.1.5 Other Drug Classes
5.2 By End-user
5.2.1 Male
5.2.2 Female
5.3 By Distribution Channel
5.3.1 Hospital Pharmacies
5.3.2 Retail Pharmacies
5.3.3 Other Distribution Channels
5.4 Geography
5.4.1 North America
5.4.1.1 United States
5.4.1.2 Canada
5.4.1.3 Mexico
5.4.2 Europe
5.4.2.1 Germany
5.4.2.2 United Kingdom
5.4.2.3 France
5.4.2.4 Italy
5.4.2.5 Spain
5.4.2.6 Rest of Europe
5.4.3 Asia-Pacific
5.4.3.1 China
5.4.3.2 Japan
5.4.3.3 India
5.4.3.4 Australia
5.4.3.5 South Korea
5.4.3.6 Rest of Asia-Pacific
5.4.4 Middle-East and Africa
5.4.4.1 GCC
5.4.4.2 South Africa
5.4.4.3 Rest of Middle-East and Africa
5.4.5 South America
5.4.5.1 Brazil
5.4.5.2 Argentina
5.4.5.3 Rest of South America

6 COMPETITIVE LANDSCAPE
6.1 Company Profiles
6.1.1 Abbott Laboratories
6.1.2 Takeda Pharmaceutical Company Limited
6.1.3 Ferring Pharmaceuticals Inc.
6.1.4 Merck KGaA.
6.1.5 Pfizer Inc.
6.1.6 Novartis International AG
6.1.7 Bayer AG
6.1.8 Theramex
6.1.9 Mankind Pharma
6.1.10 Teva Pharmaceticals Industries

7 MARKET OPPORTUNITIES AND FUTURE TRENDS

Companies Mentioned
 - Abbott Laboratories
- Takeda Pharmaceutical Company Limited
- Ferring Pharmaceuticals Inc.
- Merck KGaA.
- Pfizer Inc.
- Novartis International AG
- Bayer AG
- Theramex
- Mankind Pharma
- Teva Pharmaceticals Industries